Allergan, Inc.

Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970. It ceased operation in 2015 when it was acquired by Irish-based Actavis plc (itself a 2013 U.S. tax inversion to Ireland), who then renamed the group as Allergan plc.

This article is about the original company known as Allergan, Inc., which was acquired by and folded into Actavis. For the new company formed after the acquisition, see Allergan.
Allergan, Inc.
Company typePublic
Traded as
NYSE: AGN
IndustryEye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics
Founded1948 (1948)
Defunct2015 (2015)
FateAcquired by Actavis plc in 2015, who then renamed the group as Allergan plc
SuccessorActavis
HeadquartersIrvine, California, U.S.
Area served
Over 100 Countries
Key people
Paul Bisaro (executive chairman)
Revenue$6.2 billion (2013)
Number of employees
11400 (2013)
ParentAllergan plc
Websitewww.allergan.com
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.